TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/3/24 16:23 | 5/30/24 | HUMA | Humacyte, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Prichard Heather Ledbetter | NC | O | COO | S.dm | -1,562 | 8.15 | 0 | -192 | -100 | 0 | D | ||||||||||||||
6/3/24 16:23 | 5/30/24 | HUMA | Humacyte, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Prichard Heather Ledbetter | NC | O | COO | M.d | 350 | 2.75 | 0 | 127 | 0 | D | |||||||||||||||
5/26/23 17:05 | 5/24/23 | HUMA | Humacyte, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Prichard Heather Ledbetter | NC | O | COO | M.dm | 94 | 1.19 | 0 | 79 | 65 | D | |||||||||||||||
5/26/23 17:05 | 5/24/23 | HUMA | Humacyte, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Prichard Heather Ledbetter | NC | O | COO | S.dm | -94 | 4.01 | 0 | -23 | -27 | 65 | D | ||||||||||||||
12/13/22 16:06 | 12/12/22 | HUMA | Humacyte, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Prichard Heather Ledbetter | NC | O | COO | M.d | 8 | 1.15 | 0 | 7 | 250 | 9 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |